Pay in 4 interest-free payments of $6.12 Learn more
Ships within 48 hours · Estimated delivery Jul 27 - Aug 1
Specifications Quantity: 5mg per vial Sequence: Gly-Glu-Pro-Pro-Pro-Gly-Lys-Pro-Ala-Asp-Asp-Ala-Gly-Leu-Val Form: Lyophilized powder Purity: 99% (HPLC verified) Storage: Store the powder refrigerated (28C) or frozen, protected from light and moisture, until the printed expiry
Disclosure of interest: Daniel Ullrich: nothing to disclose, Heike Heuer: nothing to disclose, Steffen Mayerl: nothing to disclose, Dagmar Fhrer: nothing to disclose, Christoph Kleinschnitz: nothing to disclose, Friederike Langhauser: nothing to disclose E-Posters - ACUTE ISCHEMIC STROKE MANAGEMENT 01.00 - ACUTE ISCHEMIC STROKE MANAGEMENT - 01.04 - THROMBOLYSIS P2110 - ESOC25-1904 THROMBOLYSIS UTILIZATION AND OUTCOMES IN A PERIPHERAL CENTRAL HOSPITAL COHORT OF SUPRATENTORIAL ISCHEMIC STROKE Jussi Sipil 1,2 , Juha Pkknen 1 , Ayla Mehdiyeva 1,2 , Matti Heikkinen 1,2 , Mohamed Hassan 1,2 , Liisu Balk 1 , Minna Johanna Willman 1 , Albina Kettunen 1 , Anna Saukkonen 1 , Jari Toivanen 1 1 North Karelia Central Hospital, Joensuu, Finland, 2 University of Eastern Finland, Kuopio, Finland Background and Aims: IVT appears underutilised
Effect of Gly-His-Lys peptide and its analogs on pain sensitivity in mice
Is lab verification available
Conditions associated with high B12 include liver disease, renal impairment, myeloproliferative disorders, and certain malignancies
US$ 25.19
US$ 29.63
US$ 27.67
US$ 28.85
US$ 24.23
US$ 28.22
US$ 27.11
US$ 28.08
US$ 21.04
US$ 28.32
US$ 28.14